NIH-funded research U01 cooperative agreement

Gut microbiome and Parkinson's disease

Official title: A cross-sectional and longitudinal study of gut microbiota in Parkinson's disease

Funded at University of Chicago · NIH-11369336 · Data updated 2026-11-12

This project looks at gut bacteria and the chemicals they make in people with Parkinson's disease over time to find patterns linked to symptoms and progression.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startAugust 15, 2024
Project endJune 30, 2029
Funding year2025
Award (this year)$214,898
NIH project number3U01DK140936-02S1
Project IDNIH-11369336 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults diagnosed with Parkinson's disease who can provide stool samples, share their clinical history, and attend periodic follow-up visits.

Less likely to help

People seeking an immediate new therapy or those unable to provide stool samples or attend follow-up visits are unlikely to receive direct benefit from participating.

What this research studies

From your perspective, researchers will collect health information and stool samples from people with Parkinson's disease now and at planned follow-up visits. The stool samples will undergo advanced multi-omic testing, including a targeted metabolomics panel and a novel transfer RNA-based sequencing method (MSRseq) to track which microbes are present and what they are doing. The team will compare people with different ages at onset, motor and non-motor symptoms, and disease severity, and will follow changes over time. The goal is to find microbiome patterns that might predict disease course and point to gut-targeted treatments.

Why it matters

Potential benefit: If successful, this work could identify gut-based markers to help predict Parkinson's progression and suggest targets for interventions that prevent or reduce symptoms.

How similar studies have gone: Previous cross-sectional studies have reported differences in the gut microbiome of people with Parkinson's, but longitudinal evidence and causal links remain limited, so this approach builds on prior findings but is not yet proven.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Xie, Tao — University of Chicago
  • Study coordinator: Xie, Tao

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.